Drugs / RiVax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00812071 | Mar 2008 → Jan 2012 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RiVax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00812071 ↗ |
| Modality | Vaccine | “a Vaccine to Prevent the Toxic Effects of Ricin” NCT00812071 ↗ |